BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 10/15/2024 at 07:01, 1 month 6 days ago

bioMérieux obtient le marquage CE du test sanguin VIDAS® VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12
bioMérieux obtient le marquage CE pour le test sanguin VIDAS VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12, renforçant leur gamme d'immunoessais

BioMérieux Marquage CE VIDAS Vitamine B12 Test Sanguin
BRIEF

published on 10/08/2024 at 10:45, 1 month 13 days ago

Update of the number of shares and voting rights of bioMérieux

Voting Rights BioMérieux Actions Transparency Financial Market
BRIEF

published on 10/08/2024 at 10:45, 1 month 13 days ago

Actualisation du nombre d'actions et de droits de vote de bioMérieux

Marché Financier Droits De Vote BioMérieux Actions Transparence
REGULATED PRESS RELEASE

published on 10/08/2024 at 10:40, 1 month 13 days ago

Septembre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
bioMérieux annonce les informations mensuelles relatives au nombre total de droits de vote et d'actions. Nombre de droits de vote théoriques : 191 139 182

Autorité Des Marchés Financiers Droits De Vote BioMérieux Actions Informations Mensuelles
REGULATED PRESS RELEASE

published on 09/05/2024 at 07:01, 2 months 16 days ago

bioMérieux – First-Half 2024 Results
BRIEF

published on 08/06/2024 at 17:39, 3 months 14 days ago

Déclaration de bioMérieux sur les droits de vote en juillet 2024

Droits De Vote BioMérieux Actions AMF Informations Financières
BRIEF

published on 08/06/2024 at 17:39, 3 months 14 days ago

BioMérieux statement on voting rights in July 2024

Voting Rights BioMérieux Actions AMF Financial Informations
REGULATED PRESS RELEASE

published on 08/06/2024 at 17:34, 3 months 14 days ago

Juillet 2024 Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
bioMérieux communique les informations mensuelles sur le nombre total de droits de vote et d'actions au 31/07/2024 conformément aux réglementations financières

Droits De Vote BioMérieux Actions Informations Mensuelles Règlementations Financières
BRIEF

published on 07/05/2024 at 15:57, 4 months 15 days ago

BioMérieux: Information on the number of shares and voting rights in June 2024

Share Capital Voting Rights BioMérieux Actions June 2024
BRIEF

published on 07/05/2024 at 15:57, 4 months 15 days ago

BioMérieux : Informations sur le nombre d'actions et de droits de vote en juin 2024

Droits De Vote Capital Social BioMérieux Actions Juin 2024

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 5 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 5 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 35 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 2 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 5 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 30 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 50 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 58 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 5 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 35 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 7 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 57 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 45 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE